About Qiming Venture Partners
Qiming Venture Partners is a venture capital firm founded in 2006. It is primarily based out of Shanghai, China. As of Apr 2026, Qiming Venture Partners is an active investor, having invested in 515 companies, with 16 new investments in the last 12 months. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of Aureka Biotechnologies Overall, Qiming Venture Partners portfolio has seen 14 unicorns, 53 IPOs and 29 acquisitions including key companies like Meitu, Bilibili and Meituan. A lot of funds co-invest with Qiming Venture Partners, with names like TF Capital sharing a substantial percentage of its portfolio. Qiming Venture Partners has team of 46 people including 10 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 8 more
Portfolio IPOs
Portfolio Acquisitions
Deals in last 12 months
Qiming Venture Partners' List of Top Investments
Qiming Venture Partners has a portfolio of 515 companies, including 14 unicorns. Their most notable investments are in WeRide and NVXClouds.Their portfolio spans across China, United States, Singapore and 14 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 38 other sectors, across stages such as Series A, Series B and 8 more. Here is the list of top investments by Qiming Venture Partners:
1. Meitu
Developer of image, video, and design creation software and applications. The company provides tools for portrait photography, video enhancement, and e-commerce design. It offers platforms and resources for image editing and artificial intelligence solutions. The company also focuses on sustainability and corporate governance.
Key facts about Meitu
- Founded Year: 2008
- Location: Xiamen (China)
- Stage: Public
- Total Funding till date: $525M
- Employee Count: 645 as on Apr 30, 2026
- Investors: Temasek, Tiger Global Management and 19 Others
- Latest Funding Round: Post IPO, May 21, 2025, $*****
- Highlight: Public
2. Bilibili
Online video streaming platform for anime. It is themed around anime, manga, and game fandom. Users can submit, view, and add commentary subtitles on videos. The application is available for Android and iOS users. It monetizes through webpage advertisement and affiliate marketing.
Key facts about Bilibili
- Founded Year: 2010
- Location: Yangpu (China)
- Stage: Public
- Employee Count: 2,515 as on Apr 30, 2026
- Investors: Cornerstone Capital, SoftBank Group and 16 Others
- Latest Funding Round: Post IPO, May 21, 2025, $*****
- Highlight: Public
3. Pratilipi
Online self-publishing and storytelling platform offering digital literature in multiple languages. It provides a space for writers to self-publish their works, including stories, poems, articles, and novels. The platform enables readers to discover content, save favorites, listen audiobooks, and interact with writers through reviews and discussions. It fosters a community where writers and readers can connect and share their literary interests.
Key facts about Pratilipi
- Founded Year: 2014
- Location: Bengaluru (India)
- Annual Revenue: ₹82.6Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $97M
- Employee Count: 201 as on Aug 31, 2025
- Investors: Jungle Ventures, Timesgroup and 44 Others
- Latest Funding Round: Series E, Apr 03, 2025, $*****
- Highlight: Editors' Pick
4. Meituan
Online group-buying platform offering coupons for multi-category products and services. It offers coupon codes for food ordering, restaurants, dining booking, tickets, entertainment, corporate travel booking, domestic services, and more.
Key facts about Meituan
- Founded Year: 2010
- Location: Beijing (China)
- Stage: Public
- Total Funding till date: $9.86B
- Employee Count: 41,118 as on Apr 30, 2026
- Investors: Brookside Equity Partners, Temasek and 47 Others
- Latest Funding Round: Series F, Sep 01, 2018, $*****
- Highlight: Public
5. Xiaomi
Onlien brand offering consumer electronics, home appliances, and lifestyle products. The business provides phones, tablets, televisions, audio devices, and smart home products. Support services include online help, customer service, and warranty options. The company also offers exchange programs and extended warranties.
Key facts about Xiaomi
- Founded Year: 2010
- Location: Beijing (China)
- Annual Revenue: ₹24,100Cr as on Mar 31, 2025
- Stage: Public
- Total Funding till date: $1.45B
- Employee Count: 25,106 as on Apr 30, 2026
- Investors: TrueBridge, USM and 33 Others
- Latest Funding Round: Conventional Debt, Jul 27, 2017, $*****
- Highlight: Public
Qiming Venture Partners' Year-on-Year Investment Trends
Qiming Venture Partners has invested in 515 companies over the last 20 years, with an average of 25 new investments annually in the last 10 years. In 2025, it made 26 investments, while as of Apr 2026, it has made 13 investments in this year. Its most recent first time investment was in Viva Tides and most recent follow-on round was in Aureka Biotechnologies.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 7 | 6 | 13 |
2025 | 16 | 10 | 26 |
2024 | 23 | 9 | 32 |
2023 | 24 | 16 | 40 |
2022 | 38 | 12 | 50 |
2021 | 40 | 26 | 66 |
2020 | 21 | 20 | 41 |
2019 | 21 | 9 | 30 |
2018 | 26 | 15 | 41 |
2017 | 26 | 10 | 36 |
Qiming Venture Partners' Investments by Stage
Qiming Venture Partners has made 135 investments in Series A stage with an average round size of $25.7M, 104 investments in Series B stage with an average round size of $35.6M and 48 investments in Seed stage with an average round size of $16.6M.Stage of entry | No. of Investments |
|---|---|
Series A | 135 |
Series B | 104 |
Seed | 48 |
Series C | 38 |
Angel | 6 |
Others | 10 |
Note: We have considered here, only first round of investments
Qiming Venture Partners' Investments by Sector
Qiming Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Consumer, Enterprise Applications and Healthcare. Notably, it has invested in 336 Tech companies, 253 Enterprise (B2B) companies, 153 Consumer (B2C) companies and at least 120 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 93 |
High Tech | 68 |
Consumer | 60 |
Enterprise Applications | 56 |
Healthcare | 44 |
Others | 321 |
Note: We have considered here, only first round of investments
Qiming Venture Partners' Investments by Geography
Qiming Venture Partners has made most investments in China (270), followed by United States where it has made 41 investments.Country | No. of Investments |
|---|---|
China | 270 |
United States | 41 |
Singapore | 5 |
Indonesia | 2 |
Netherlands | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
Qiming Venture Partners' recent investments
Qiming Venture Partners has made 13 investments in 2026 so far. Aureka Biotechnologies and Pulnovomed are the latest among them.Here are the most recent investments by Qiming Venture Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 28, 2026 | United States | Series A | 4923 | ||
Apr 20, 2026 | United States | Series C | 7954 | [+5] | |
Apr 10, 2026 | United States | Series A | 7681 | [+2] | |
Apr 09, 2026 | China | Series D | 5474 | [+6] | |
Mar 31, 2026 | China | Series B | 5965 | [+11] |
Unicorns in Qiming Venture Partners' Portfolio
Qiming Venture Partners has 14 unicorns in its portfolio - Scroll, Akulaku, Matrixport and others. The most recent unicorn in their portfolio is Scroll. It became a unicorn in 2023.Here is a list of unicorns in Qiming Venture Partners' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
66 | Blockchain-based network for EVM-compatible solutions | 2013 | - | Series B | pp{ptyc | ||
66 | Online marketplace for point of sale financing | 2014 | Jakarta | Series E | fewftjl | ||
73 | App-based platform offering crypto investment products and financial services solutions | 2019 | Singapore | Series C | rxoccgd | ||
42 | Developer of mRNA-based therapeutics for cancer and infectious diseases | 2019 | Suzhou | Series C | ccezdym | ||
43 | Online distributor of groceries facilitating group buying | 2018 | Chaoyang | Series D | ismadbf |
IPOs and Publicly Listed companies in Qiming Venture Partners' Portfolio
53 of Qiming Venture Partners' portfolio companies have become public. Alamar Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2026 at marketcap of $1.14B and Axera got listed on the Hong Kong Exchanges (HKG) at marketcap of $2.12B.Here are Qiming Venture Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 17, 2026 | Sep 08, 2021 | Series B | 3392 | |
Feb 10, 2026 | Apr 07, 2021 | Series A | 8923 | |
Feb 05, 2026 | Dec 31, 2020 | Series C | 5332 | |
Jan 08, 2026 | Sep 2022 | Series B | 3526 | |
Jan 02, 2026 | Jun 15, 2020 | Series A | 4331 |
Acquired companies in Qiming Venture Partners' Portfolio
29 companies from Qiming Venture Partners' portfolio have been acquired. The most recent acquisition was Ventyx Biosciences in Jan 2026 by Lilly for $*****.Here are Qiming Venture Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 07, 2026 | Sep 09, 2021 | Series B | 6673 | |
Nov 13, 2025 | May 04, 2011 | Series C | 3740 | |
Dec 12, 2023 | Apr 07, 2021 | Series B | 1367 | |
Aug 23, 2022 | - | - | 9115 | |
Jun 17, 2022 | Nov 28, 2018 | Series B | 5493 |
_1543472265233.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of Qiming Venture Partners
Qiming Venture Partners has a team of 46 members including 10 Partners, 3 Venture Partners and 16 Principals located in China, United States and 1 more location. Qiming Venture Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Qiming Venture Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Seattle | - | ||
Partner | Shanghai | - | ||
Partner | China | - | ||
Partner | Pudong | - | - | |
Partner | Chaoyang | - | ||
Partner | Seattle | - | ||
Partner | - | - | ||
Partner | Los Angeles | - | ||
Partner | - | - | ||
Partner | China | - | ||
Venture Partner | San Diego | - | - |
Co-investors of Qiming Venture Partners
Over the past 20 years, 1499 investors have co-invested in Qiming Venture Partners's portfolio companies. This includes funds and angels.
- Invested before Qiming Venture Partners: IDG Capital, Matrix Partners China and 351 others have invested in rounds before Qiming Venture Partners. There are 14 companies where IDG Capital has invested before Qiming Venture Partners and 10 companies where Matrix Partners China has invested before Qiming Venture Partners.
- Top Co-investors of Qiming Venture Partners: 506 investors entered a company along with Qiming Venture Partners. These include investors like TF Capital (14 companies).
- Invested after Qiming Venture Partners: A total of 640 investors have invested in Qiming Venture Partners's portfolio after their investments. Top Investors include Tencent (16 companies), Temasek (10 companies) and Hillhouse (10 companies).
Recent News related to Qiming Venture Partners
•
DeepSeek Secures $250 Million in Funding Led by Qiming Venture PartnersEconomic Daily•May 21, 2026•DeepSeek, Qiming Venture Partners
•
•
SHINEBED Secures Tens of Millions of USD in Series A Fundinglejucaijing.com•May 08, 2026•Qiming Venture Partners,
•
造物时代融资数亿元，打破消费级CNC赛道最大融资纪录The Paper•May 06, 2026•Makera, CMB International Capital, Qiming Venture Partners
•
Vivacta Bio Secures Over $50 Million in Series A and A+ FinancingPR Newswire•Apr 29, 2026•Loayal Valley Capital, Decheng Capital, , Eisai Innovation and 3 others
•
Pulnovo Medical Announces Strategic Investment from Medtronic in $100 Million FinancingPR Newswire•Apr 20, 2026•Medtronic, Pulnovomed, LAV, HSG and 4 others
•
Vivatides Therapeutics Completes $54M Series A Funding Roundmedvalley.cn•Apr 10, 2026•Shanghai Hengrui Pharmaceutical, Qiming Venture Partners, Hlc Fund, Apricot Capital and 3 others
•
OriCell Raises $40M More as It Looks to Go PublicEndpoints•Apr 10, 2026•OriCell Therapeutics, Vivo Capital, Qiming Venture Partners
•
Syneron Bio Closes $150M Series B FinancingFinSMEs•Apr 03, 2026•LAV, Global League, True Light Capital, 5Y Capital and 10 others
•
StairMed Raises RMB 500M in FundingFinSMEs•Apr 02, 2026•LAV, StairMed Technology, FountainBridge Capital, Oriza Holdings and 5 others
